Activation-induced T-cell exhaustion: too much of a good thing?: Leukemia & Lymphoma: Vol 61, No 2

113

Views

CrossRef citations to date

Altmetric

"Activation-induced T-cell exhaustion: too much of a good thing?." Leukemia & Lymphoma, 61(2), pp. 255–256

Disclosure statement

No potential conflict of interest was reported by the author.

Additional information

Funding

Stephen Ansell received research funding (to his institution for clinical trials) from Bristol Myers Squibb, Merck, Seattle Genetics, Regeneron, Trillium, AI Therapeutics, Pfizer and Affimed.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Activation-induced T-cell exhaustion: too much of a good thing?

Information for

Open access

Opportunities

Help and information

Activation-induced T-cell exhaustion: too much of a good thing?

Disclosure statement

Additional information

Funding

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature